14th May 2025 · SEBI-Registered Analyst
STAROFMARKET ADVICE with MAYANK (SEBI RA) · 14th May 2025
Auro Pharma
AUROPHARMA Auro Pharma: Subsidiary has received UK MHRA approval for Zefylti, a filgrastim biosimilar. (Positive)
#TechnicalViews#FundamentalViews
259 likes·66 comments